Oxfam: Patent laws kill thousands

Oxfam says that patents laws denying the poor access to crucial medicines.

    Thousands of patients in developing countries cannot afford medicines (Picture: Getty/ Gallo)

    Steve Cockburn, the Stop Aids campaign co-ordinator, said: "At the time, the Doha Declaration seemed like a great breakthrough for people in poor countries who urgently needed affordable treatment.

    "Sadly, promising words have not translated into life-saving treatments."

    The agreement, signed five years ago, was designed to put patients before profits and allow local pharmaceutical manufacturers to provide cheaper medicine for patients in developing countries.

    Health activists say that access to cheap generic drugs is vital if poor countries are going to put up an effective fight against fatal diseases such as Aids and malaria.

    In 2001 the World Trade Organisation granted a special exemption to allow countries to put public health ahead of patents within its Trade Related Aspects of Intellectual Property Rights (Trips) agreement.
       
    But Oxfam said that rich countries, particularly the US, were bullying developing countries to impose stricter patent rules in order to preserve pharmaceutical monopolies.

    Innovative treatment

    The clash over patents in the developing world has focused attention on two high-profile cases including a dispute over the cancer drug Glivec, made by Switzerland's Novartis.
       
    An Indian court rejected its patent application for Glivec in January, but Novartis is fighting back, arguing that the principle of intellectual property protection must be protected if innovation is to flourish.
       
    The ruling has minimal commercial significance because 99 per cent of Indian patients are entitled to receive the drug free of charge under a Novartis compassionate-use programme.
       
    But Paul Herrling, the company's head of corporate research, told the Reuters Health Summit last week that India risked falling behind China in drug research if it did not shore up its weak patent protection system.

    SOURCE: Al Jazeera and agencies


    YOU MIGHT ALSO LIKE

    'Money can't buy us': Mapping Canada's oil pipeline battle

    'Money can't buy us': Mapping Canada's oil pipeline battle

    We travel more than 2,000km and visit communities along the route of the oil pipeline that cuts across Indigenous land.

    Women under ISIL: The wives

    Women under ISIL: The wives

    Women married to ISIL fighters share accounts of being made to watch executions and strap explosives to other women.

    Diplomats for sale: How an ambassadorship was bought and lost

    Diplomats for sale: How an ambassadorship was bought and lost

    The story of Ali Reza Monfared, the Iranian who tried to buy diplomatic immunity after embezzling millions of dollars.